US OptionsDetailed Quotes
HIMS241011C15000
- 2.73
- +0.78+40.00%
15min DelayClose Oct 4 15:59 ET
2.73High1.95Low
1.95Open1.95Pre Close26 Volume137 Open Interest15.00Strike Price5.49KTurnover101.78%IV0.40%PremiumOct 11, 2024Expiry Date2.66Intrinsic Value100Multiplier4DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.9368Delta0.0632Gamma6.48Leverage Ratio-0.0276Theta0.0017Rho6.07Eff Leverage0.0024Vega
Hims & Hers Health Stock Discussion
nailed it
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
No comment yet